1. Home
  2. SQNS vs ATYR Comparison

SQNS vs ATYR Comparison

Compare SQNS & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sequans Communications S.A.

SQNS

Sequans Communications S.A.

HOLD

Current Price

$3.15

Market Cap

46.4M

Sector

Technology

ML Signal

HOLD

Logo aTyr Pharma Inc.

ATYR

aTyr Pharma Inc.

HOLD

Current Price

$0.49

Market Cap

51.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SQNS
ATYR
Founded
2003
2005
Country
France
United States
Employees
N/A
58
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.4M
51.7M
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
SQNS
ATYR
Price
$3.15
$0.49
Analyst Decision
Strong Buy
Hold
Analyst Count
3
9
Target Price
$20.33
$3.67
AVG Volume (30 Days)
69.3K
2.2M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$49.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.73
$0.40
52 Week High
$10.93
$7.29

Technical Indicators

Market Signals
Indicator
SQNS
ATYR
Relative Strength Index (RSI) 43.96 43.42
Support Level $2.86 $0.43
Resistance Level $3.27 $0.86
Average True Range (ATR) 0.23 0.06
MACD 0.00 -0.00
Stochastic Oscillator 35.82 0.05

Price Performance

Historical Comparison
SQNS
ATYR

About SQNS Sequans Communications S.A.

Sequans Communications SA is a fabless semiconductor company specializing in wireless 4G and 5G cellular technologies for the Internet of Things (IoT). Sequans' engineers design and develop, secure, and energy-efficient semiconductor solutions that enable the next generation of AI-connected applications, including smart energy metering, industrial automation, smart mobility and logistics, secure payments, e-health, and smart home solutions. The Company offers a comprehensive portfolio of wireless connectivity solutions, including radio frequency (RF) transceivers, integrated circuits (ICs) for baseband processing, as well as modules, software, & protocol stacks. The Company has one operating segment, which is the design & marketing of semiconductor components for cellular wireless systems.

About ATYR aTyr Pharma Inc.

aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Share on Social Networks: